Body Mass Research Articles

Acute and chronic effects of methanolic extract of Teucrium polium on blood parameters and histopathology of liver and kidney in Female Rats

Teucrium polium L. is commonly used as a medicinal plant in Algeria to fight various human diseases. In this study, extracting aerial parts of T. polium with methanol gave a dry matter yield of 8.24 %. The effects of methanolic extract of T. polium "TPME" were examined per os on female rats Albino Wistar for six weeks. Biochemical and hematological serum parameters and morphology and histopathology of organs of treated rats were studied. Acute toxicity showed low toxicity with a lethal dose of 50% LD50 > 2400 mg / Kg of body weight. These data can be used to classify these plants as slightly toxic. However, sub-acute treatment for six weeks of rats with 75, 150, and 300 mg of methanolic extract / Kg of body weight significantly increased the most studied hematological parameters. Biochemical analysis revealed a significant increase of renal parameters (urea, creatinine, uric acid, Na, and K), accompanied by an increase in the relative weight of kidney, lipidic (cholesterol), and hepatic glutamate oxaloacetate transaminase (GOT) values in all treated rats. Histopathological examination confirmed the biochemical tests by the observation of perilobular necrosis areas, bile duct and inflammatory infiltration of the liver, and the presence of marked intracytoplasmic vacuoles in the kidney with the dose 300 mg of TPME Kg of animal body weight. Use of Teucrium polium L. may cause hepatotoxicity and nephrotoxicity after prolonged herb administration. Keywords: Teucrium polium L, TPME, LD50, biochemical parameters, toxicity

Abstract B008: Twist1 drives pancreatic ductal adenocarcinoma-mediated muscle cachexia

Abstract Cancer cachexia is a debilitating syndrome that affects the survival and quality of life of cancer patients. Up to 95% of pancreatic ductal adenocarcinoma (PDAC) patients experience muscle cachexia, yet the underlying mechanisms remain poorly understood. The transcription factor Twist1 plays essential roles in mesenchymal stem cell fate determination, and its deregulation contributes to cancer progression and metastasis. In this study, we report on the serendipitous finding that Twist1 functions in PDAC to drive muscle cachexia. We found that conditional overexpression of Twist1 in the pancreatic epithelium (pTwist1) during early development resulted in severe growth retardation, which was mainly characterized by muscle hypotrophy. This intriguing observation prompted us to inquire whether pTwist1 could function in the pancreatic epithelium to regulate muscle mass, and if so, whether this has any implication as it relates to PDAC-mediated muscle cachexia. We found that enforced expression of pTwist1 in healthy adult animals was sufficient to elicit the cardinal features of muscle cachexia, including progressive decline in body weight, physical activity, muscle force, and muscle mass. In the context of PDAC, enforced expression of pTwist1 in a KrasG12D background led to a dramatic acceleration of tumor progression, and this was associated with severe muscle cachexia. To the best of our knowledge, these findings provide the first evidence that the pro-malignant transcription factor Twist1 functions in PDAC to drive muscle cachexia, thus revealing new insights into the underlying mechanisms of muscle that could be harnessed to curb this debilitating syndrome. Citation Format: Parash Parajuli, Azeddine Atfi. Twist1 drives pancreatic ductal adenocarcinoma-mediated muscle cachexia [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research; 2024 Sep 15-18; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2024;84(17 Suppl_2):Abstract nr B008.

Investigating the availability of omega-3 fatty acid from different sources and its effect on table eggs

The impact of three different commercial omega-3 fortifying agents on the growth performance, egg weight, egg production, and omega-3 fatty acid enrichment of white table eggs in layers was investigated. The experiment involved 12,000-layer birds randomly divided into four groups, with each group replicated three times and consisting of 1000 birds per replicate. The three groups, namely LP, AG, and DD, were supplemented with omega-3 fortifying agents LinPro, All-G-Rich, and DHA-gold, respectively, while the fourth group NC served as a negative control without omega-3 fortifying agent supplementation. The experiment commenced after the 25th week of age and lasted for a period of four weeks in a completely randomized design. Egg weight and egg production were recorded weekly, while the omega-3 fatty acid content of the white eggs was determined at the end of the 30-day trial after the 25th week of age. The supplementation of different omega-3 fortifying agents significantly impacted feed intake, with notable differences observed among weekly and overall means. Birds supplemented with LinPro consumed less feed during the 2nd and 4th week of the trial compared to the control, resulting in an overall reduction of 1.1 g/chick in feed intake. However, supplementation did not significantly affect the body weight of layers throughout the trial, nor did it impact egg weight or production. Nevertheless, the omega-3 fortifying agents had a significant effect on the omega-3 fatty acid content of the white table eggs in layers. LinPro supplementation notably increased α-linolenic acid (18:3; ALA) and eicosapentaenoic acid (20:5; EPA) levels, while DHA-Gold resulted in the highest docosahexaenoic acid (22:6; DHA) content. Total fatty acid content was highest in eggs from layers supplemented with LinPro, followed by DHA-Gold and All-G-Rich, with the lowest levels observed in the control group. These findings suggest that dietary supplementation of LinPro in layer diets post the 25th week of age could effectively enhance the omega-3 fatty acid content of white table eggs without compromising feed intake, body weight, egg weight, or egg production.

Acute toxicity assessment of bioactive constituents from Salvia algeriensis (Desf.) extracts: a promising natural agent against clinical bacterial isolates and pathogenic fungi

Salvia species are emerging as promising therapeutic agents due to their diverse bioactivity against various pathologies. This study was conducted to investigate the phytochemical profile, antimicrobial activity, and acute Toxicity of hydromethanolic extracts from Salvia algeriensis (Desf.) leaves, flowers, and roots. Chemical reaction tests and chromatographic analysis were employed to determine the chemical composition, while microdilution was used to determine the tested microorganisms' minimum inhibitory concentration (MIC). The acute Toxicity of the leaf extract was carried out following the rules and guidelines of OECD 425. Toxicity parameters in Swiss albino mice were evaluated after a single dose of 500 mg/kg and 2000 mg/kg. According to the preliminary phytochemical screening results, terpenoids and polyphenols (flavonoids and tannins) were found in all plant parts, but coumarins were only found in the root extract. The HPLC-DAD analysis revealed the presence of 16 phenolic compounds in varying amounts across the three extracts, of which rosmarinic acid, quercetin, caffeic acid, and 3-hydroxybenzoic acid were the most abundant. Selective antimicrobial activity was noticed, with the root extract demonstrating the most substantial effect against the two fungal strains tested. MIC values ranged from 0.3 to 10 mg/mL, and Gram-positive bacteria generally showedgreater susceptibility compared to Gram-negative bacteria. The LD50 was found to be greater than 2000 mg/kg. There were no overt clinical symptoms of Toxicity. Body weights, organ weights, and temperatures were not significantly altered, and hematological analysis showed no significant differences. Salvia algeriensis (Desf.) extracts emerge as potential candidates for natural, non-toxic antimicrobial agents. Keywords: Acute Toxicity; antimicrobial; HPLC-DAD; polyphenols; Salvia

Abstract B012: Randomized phase II trial of two different nutritional approaches for patients receiving treatment for their advanced pancreatic cancer: initial results of safety and feasibility of the medically supervised ketogenic diet

Abstract Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by stromal fibrosis, hypoxia, and nutritional deprivation. Nutritional metabolic interventions may fundamentally change the tumor microenvironment and improve outcomes. A ketogenic diet (KD) (lower carbohydrate, moderate protein, higher fat) can significantly reduce glucose and insulin and stimulate ketogenesis. Triplet chemotherapy with gemcitabine/cisplatin/nab-paclitaxel has been associated with a median OS 16.4 months, PFS 10.1 months in patients with metastatic PDAC in the first-line setting. Recently, KD plus triplet chemotherapy was shown to inhibit murine pancreatic KPC tumor growth and prolong animal survival over chemotherapy alone (Yang et al, Med, 2022). Tumor growth inhibition was associated with glucose depletion, altered TCA substrate use and NADH elevation. Methods: In this Phase II trial, patients with treatment-naive metastatic PDAC were randomized to triplet chemotherapy with a medically supervised ketogenic diet (MSKD) or continuing their usual diet (non-MSKD). The MSKD is supported by Virta Health, who offers tracking of daily ketone (beta-hydroxybutyrate, BHB) and glucose levels, a web-based application, education, and communication with a remote care team to ensure sustained nutritional ketosis (BHB 0.5–3.0mM). Patients with BMI < 18, type 1 DM or history of DKA were excluded. Primary endpoint was PFS. Secondary endpoints: DCR (PR+CR+SD ≥ 9 weeks), change in CA 19-9 (CA125, CEA if not CA 19-9 expressers), average fasting insulin levels, HbA1c, body weight, gut microbiome, serum metabolites, QOL (QLQ- C30). Results: A total of 36 patients with untreated metastatic PDAC were enrolled. Among 32 evaluable patients (median age 65.9 years; 53% male), 16 were randomized to each arm. Both groups had similar baseline weight, HgbA1c, insulin and BHB levels (all p>0.05). Nine patients had type 2 DM; 6 required insulin. In the MSKD group, 15/16 achieved nutritional ketosis at any point during the study, with mean BHB of 0.57 mM (95% CI 0.40–0.73) and median proportion of days in ketosis of 39.4% (range 0-95.8%) by daily ketone tracking. Lab data showed significantly higher mean ± SD maximum change in BHB in the MSKD (0.5 ± 0.9 mmol/L) versus non-MSKD (–0.2 ± 0.3 mol/L) group (p = 0.018). There were no significant differences between groups in maximum change in weight, HbA1C, or insulin (all p > 0.05). The most common MSKD-related adverse events were Gr 1-2 fatigue (n=4), constipation (n=3), weight loss (n=3), and none stopped MSKD due to adverse events.Conclusion: A medically supervised ketogenic diet is feasible in patients with metastatic PDAC receiving triplet chemotherapy, with median proportion of days in ketosis of 39.4% and an acceptable safety profile. The MSKD is associated with comparable changes in insulin and HgbA1c levels compared to the non-MSKD diet, and sustained ketosis does not result in significantly greater weight loss. MSKD warrants further prospective exploration and analyses of the primary endpoint and correlative studies are ongoing. Citation Format: Gayle S Jameson, Erkut Borazanci, Diana L Hanna, Caroline GP Roberts, Meredith S Pelster, Richard C Frank, Angela T Alistar, Julia E Wiedmeier-Nutor, Sandra D Algaze, Brandon Fell, Sarah J Hallberg, Denise J Roe, Betsy C Wertheim, Derek Cridebring, Joshua D Rabinowitz, Stephen Gately, Daniel D Von Hoff, Drew W Rasco. Randomized phase II trial of two different nutritional approaches for patients receiving treatment for their advanced pancreatic cancer: initial results of safety and feasibility of the medically supervised ketogenic diet [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research; 2024 Sep 15-18; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2024;84(17 Suppl_2):Abstract nr B012.

Occurrence of Ectoparasites on Tilapia zillii (Red Belly Tilapia) Gervais 1848 in The Tono Reservoir, Navrongo, Ghana

This study was carried out to assess the occurrence of endoparasites in (Tilapia zillii (Gervais, 1848)) from Tono reservoir, Navrongo Ghana. A total of 120 fish samples were collected from the upstream, midstream and downstream regions of the reservoir using cast nets. All the collected fish samples were transported to the research laboratory in the University for Development Studies and examined for ectoparasites during January 2022 to August 2022. Five ectoparasites namely Trichodina sp. of Protozoans ciliates, Dactyolgyrus sp. of Monogenean, Argulus sp. and Lernaea sp. of Crustaceans and the Diplostomum sp were identified. Overall prevalence of the fish parasites was 52.32 %. Intensity of the parasites observed ranged between 1.58% to 3.52%. Highest prevalence 70 % was reported in dry season while lowest (31.67%) was reported in the rainy season. Female fish samples had higher prevalence (64.47 %) than males (27.27 %). Fishes of downstream had highest prevalence (92.5 %) than upstream (17.5 %). Fish samples with maximum length and weight were highly (65.15 %) infected than small sized fish with low body length and weight (33.33 %). It is debatable if the degree of ectoparasite activity found in this study will constitute a serious danger to the local fish population. Yet, in order to stop disease outbreaks brought on by an increase in ectoparasites, the reservoir must be given significant attention by using optimum management strategies. This study shows that dry season affects the fish business and result in poor quality fish meat with risk of diseases infection.

Investigating the Effects of Dietary Supplementation and High-Intensity Motor Learning on Nutritional Status, Body Composition, and Muscle Strength in Children with Moderate Thinness in Southwest Ethiopia: A Cluster-Randomized Controlled Trial

Background: In Ethiopia, moderate thinness (MT) is a persistent issue among children. Yet, evidence on the effects of dietary supplementation and motor skills training in these children is limited. Objective: This study aimed to assess the effect of Ready-to-Use Supplementary Food (RUSF), whether or not combined with high-intensity motor learning (HiML), on weight, height, body composition, and muscle strength in children 5–7 years old with MT living in Jimma Town, Ethiopia. Methods: A cluster-randomized controlled trial was carried out among 69 children (aged 5–7) with MT assigned to receive RUSF (n = 23), RUSF + HiML (n = 25), or no intervention (control group, n = 21). A multivariable Generalized Estimating Equations model was used and the level of significance was set at alpha < 0.05. Results:At baseline, there were no significant differences in the outcome measurements between the RUSF, RUSF + HiML, and control groups. However, after 12 weeks of intervention, there were significant mean differences in differences (DIDs) between the RUSF group and the control arm, with DIDs of 1.50 kg for weight (p < 0.001), 20.63 newton (N) for elbow flexor (p < 0.001), 11.00 N for quadriceps (p = 0.023), 18.95 N for gastrocnemius sup flexor of the leg (p < 0.001), and 1.03 kg for fat-free mass (p = 0.022). Similarly, the mean difference in differences was higher in the RUSF + HiML group by 1.62 kg for weight (p < 0.001), 2.80 kg for grip strength (p < 0.001), 15.93 for elbow flexor (p < 0.001), 16.73 for quadriceps (p < 0.001), 9.75 for gastrocnemius sup flexor of the leg (p = 0.005), and 2.20 kg for fat-free mass (p < 0.001) compared the control arm. Conclusion: RUSF alone was effective, but combining it with HiML had a synergistic effect. Compared to the control group, the RUSF and RUSF + HiML interventions improved the body composition, height, weight, and muscle strength of the studied moderately thin children. The findings of this study suggest the potential that treating moderately thin children with RUSF and combining it with HiML has for reducing the negative effects of malnutrition in Ethiopia. Future research should explore these interventions in a larger community-based study. This trial has been registered at the Pan African Clinical Trials Registry (PACTR) under trial number PACTR202305718679999.

Additive efficacy of natural versus synthetic feed additive on cellular immunity and egg quality in layers

Feed additives are the products used in animal diets for the purpose of improving the quality of feed and the quality of food from animal origin or to improve animal performance and health. The present study was planned to evaluate the beneficial effect of two edible dried mushrooms, probiotics, antioxidant and antibiotic on layer performance, cellular immunity, and antioxidant activities under hot climatic conditions. In this trial, three hundred W-98 commercial hens of 35th week of age were randomly assigned to six dietary treatments, replicated five times with 10 hens per replicate for 12 weeks. Dietary treatments were as follows; antibiotic (enramycin) 50g/ 50 kg, probiotics 50g/ 50 kg, antioxidant (ethoxyquine) 60 ppm, organic acid 50g / 50 kg; Oyster mushroom and button mushroom 1% of feed bag. The data revealed that initial, final body weight, egg production (%) and feed intake, egg specific gravity, egg shape index, egg yolk index and shell thickness and livability were non-significant (p<0.05) in all treatments. Egg weight, feed to egg mass ration, Haugh unit and damaged eggs were significantly (p>0.05) higher among different treatment groups. Total anti-oxidative capacity was significantly (p>0.05) higher in ethoxyquine, followed by oyster mushroom, button mushroom, negative control (without any feed additives), probiotics and enramycin (positive control / antibiotic). Antioxidant parameters like super oxide dismutase was significantly (p>0.05) higher in ethoxyquine followed by probiotics, oyster mushroom, button mushroom, negative control, and positive control treatments groups. Immunity parameters like catalase (interferon gamma) was non-significant (p>0.05) in all treatment’s groups. IFN-γ (Interferon-gamma) was significantly (p<0.05) higher in oyster mushroom and ethoxyquine followed by probiotics, button mushroom, negative control (without any feed additives) and positive control (with antibiotic). IL-10 (Interleukin-10) was significantly (p<0.05) higher in button mushroom, oyster mushroom and probiotics followed by ethoxyquine, negative control (without any feed additives) and positive control (with antibiotic). On whole mushrooms are effective feed additives in poultry production IFN-γ (Interferon-gamma) was significantly (p<0.05) higher in oyster mushroom and ethoxyquine followed by probiotics, button mushroom, negative control (without any feed additives) and positive control (with antibiotic). IL-10 (Interleukin-10) was significantly (p<0.05) higher in button mushroom, oyster mushroom and probiotics followed by ethoxyquine, negative control (without any feed additives) and positive control (with antibiotic). On whole mushrooms are effective feed additives in poultry production

Enhancing calcium and phosphorus utilization in broiler chickens with phytase in sequential calcium-phosphorus-deficient diets

ABSTRACT In this trial, a 3 × 2 factorial design was implemented with dietary treatments consisting of Diet-1 (1.00% calcium [Ca], 0.45% available phosphorus [P]), Diet-2 (0.80% Ca, 0.35% P), and Diet-3 (0.70% Ca, 0.30% P), alongside two phytase levels: 0 and 5,000 FTU/kg. A total of 540 Ross-308 broilers were used. Significant improvements (P < 0.05) in body weight gain, feed intake, feed conversion ratio (FCR), live weight, carcass weight, and yield were observed in Diet-1 and Diet-2 when supplemented with phytase compared to Diet-3. Gross energy (GE) increased significantly (P < 0.05) with phytase in Diet-1 and Diet-2. Bone ash content was significantly higher (P < 0.01) in Diet-1 and Diet-2, with tibia Ca levels notably improved (P < 0.05) in Diet-1. Phytase supplementation also resulted in significantly elevated (P < 0.05) serum Ca and available P in Diet-1. The application of phytase restored body weight gain, live weight, carcass weight, GE, and tibia P in Diet-2. Overall, the findings highlight the beneficial effects of phytase supplementation on growth performance, bone mineralization, and nutrient utilization.

Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.

Previous results from this trial showed longer overall survival after treatment with nivolumab plus ipilimumab or with nivolumab monotherapy than with ipilimumab monotherapy in patients with advanced melanoma. Given that patients with advanced melanoma are living longer than 7.5 years, longer-term data were needed to address new clinically relevant questions. We randomly assigned patients with previously untreated advanced melanoma, in a 1:1:1 ratio, to one of the following regimens: nivolumab (1 mg per kilogram of body weight) plus ipilimumab (3 mg per kilogram) every 3 weeks for four doses, followed by nivolumab (3 mg per kilogram) every 2 weeks; nivolumab (3 mg per kilogram) every 2 weeks plus placebo; or ipilimumab (3 mg per kilogram) every 3 weeks for four doses plus placebo. Treatment was continued until the occurrence of disease progression, unacceptable toxic effects, or withdrawal of consent. Randomization was stratified according to BRAF mutation status, metastasis stage, and programmed death ligand 1 expression. Here, we report the final, 10-year results of this trial, including results for overall survival and melanoma-specific survival, as well as durability of response. With a minimum follow-up of 10 years, median overall survival was 71.9 months with nivolumab plus ipilimumab, 36.9 months with nivolumab, and 19.9 months with ipilimumab. The hazard ratio for death was 0.53 (95% confidence interval [CI], 0.44 to 0.65) for nivolumab plus ipilimumab as compared with ipilimumab and was 0.63 (95% CI, 0.52 to 0.76) for nivolumab as compared with ipilimumab. Median melanoma-specific survival was more than 120 months with nivolumab plus ipilimumab (not reached, with 37% of the patients alive at the end of the trial), 49.4 months with nivolumab, and 21.9 months with ipilimumab. Among patients who had been alive and progression-free at 3 years, 10-year melanoma-specific survival was 96% with nivolumab plus ipilimumab, 97% with nivolumab, and 88% with ipilimumab. The final trial results showed a continued, ongoing survival benefit with nivolumab plus ipilimumab and with nivolumab monotherapy, as compared with ipilimumab monotherapy, in patients with advanced melanoma. (Funded by Bristol Myers Squibb and others; CheckMate 067 ClinicalTrials.gov number, NCT01844505.).

Maternal metformin administration during the pre-gestation period improves transient cerebral ischemia injury in male offspring rats

Purpose: It seems that maternal intervention, which may involve epigenetic mechanisms, can affect cerebral ischemia in offspring. Metformin consumption by the mother activates the AMP-activated protein kinase (AMPK) pathway. Metformin has also induced the AMPK and protected neurons in cerebral ischemia. This study investigates the effect of maternal metformin administration, which activates the AMPK pathway, on cerebral ischemia in offspring Methods: Animals were separated into four groups: sham, 2-vessels occlusion (2VO), Met+2VO, Met+compound c (CC)+2VO. Female rats were administrated with metformin at a dose of 200 mg.kg-1 body weight for 2 weeks prior to mating. After the final metformin injection, each female rat was paired with an intact adult male to allow for mating. Sixty-days old offspring underwent cerebral ischemia and then memory-related tests were done. Results: Current data revealed that the neurological deficits score was reduced Met+2VO group (P&lt;0.001), and the memory increased (P&lt;0.001) in comparison to the 2VO. The Bcl-2/Bax ratio declined in the metformin group (P&lt;0.001) while the Brain-Derived Neurotropic Factor (BDNF), c-fos, p-AMPK/AMPK ratio and Histone H3K9 acetylation in the hippocampus augmented significantly compared to the 2VO group (P&lt;0.001). Conclusion: These findings indicated that the metformin intervention via AMPK activation could improve the movement disability, enhance spatial memory, increase neural plasticity, and augment the bioenergetics state and histone acetylation in the hippocampus of the offspring.

PSLBI-22 Identifying plasma metabolites influencing body weight in Salmonella challenged growing pigs: A machine learning approach

Abstract Body weight (BW) is an important component of pig productivity. Understanding the metabolic factors affecting growth rate is key to guiding nutritional strategies and bringing economic benefits to pig farms. Machine learning (ML) algorithms have been used to capture patterns in large datasets and predict animal production traits based on integrated information of performance data and blood records. However, utilizing ML models and metabolomic profiling to predict BW of pigs in small datasets with challenged animals has yet to be reported. Therefore, this study investigated use of plasma metabolites in predicting BW of pigs at the growing stage. This simulation used data from gilts (n = 40; BW = 25.6 ± 2.3 kg) raised over a 28-d trial. Plasma samples and BW were collected on d 0, 14, and 28 after 8 h of fasting. Ninety plasma metabolites were identified and quantified from an untargeted metabolomics assay. The development dataset included 30, and the validation dataset contained 10 unique animals with repeated measures in time. The metabolites were log-transformed, Pareto-scaled and missing values were imputed using the minimum nonzero value method. The BW prediction model was performed in R with the caret package. The optimal hyper-parameter configuration for the random forest and neural network algorithms was evaluated based on repeated cross-validation. The final model was the random forest composed of 400 trees with 45 randomly selected predictors. Model accuracy was estimated on repeated cross-validation with 10-folds and 5 repeats and compared with the validation set based on the coefficient of determination (R2), the root mean squared error (RMSE), and Pearson correlation (r). The metabolites with greater contribution with variable importance score above 10 to the model development were extracted. Aiming to understand differences in BW categories, the model response was visualized with an alluvial diagram for the 3 variables with the greatest metabolite importance, and BW was classified as high, medium, and low. The main metabolites driving BW were lysine, oleic acid, aminomalonic acid, myo-inositol, and linoleic acid. The RMSE after cross-validation was 7.22 kg of BW (r = 0.70), and R2 = 0.39. For pigs with a high BW, the predicted BW was explained by generally less plasmatic concentrations of lysine, oleic acid, and aminomalonic acid. Lysine is the main amino acid for muscle protein accretion, whereas oleic acid is for energy substrate. Aminomalonic acid is a metabolite resulting from glycine metabolism and is important in reversing oxidative damage caused by pathogens. Therefore, decreased plasma lysine, amino malonic acid, and oleic acid may indicate faster growth and lean deposition, leading to heavier BW in pigs. Using random forests helped to connect the plasma dynamics to BW and is a promising avenue to understand the main drivers in BW of group-housed pigs.

Association between body weight and tocilizumab effectiveness in rheumatoid arthritis: results from the BSRBR-RA.

Tocilizumab is an IL-6 receptor humanised monoclonal antibody for the treatment of rheumatoid arthritis (RA) with intravenous (IV) and subcutaneous (SC) preparations available. Only IV tocilizumab is dosed adjusting for weight. Therefore, we aimed to study the association between body weight and the effectiveness of tocilizumab by the route of administration. Patients with RA administered tocilizumab in the BSRBR-RA were included in the analysis and stratified by route of administration. Outcomes included the 6 month change in DAS28, the proportion of patients achieving DAS28 remission, 6-month EULAR response and persistence of the first route of tocilizumab administration. The exposure was every increase in 10 kg of body weight. Adjusted regression models appropriate to outcome were used to study the associations between body weight and outcomes. Multiple imputations accounted for missing data. 2612 patients were included. Body weight was associated with reduced response to SC tocilizumab measured by change in DAS28: adjusted regression coefficient (95% CI) all patients 0.01 (-0.04, 0.07); IV: -0.03, (-0.1, 0.5); SC: 0.1 (0.02, 0.2) but not odds in achieving DAS28 remission or EULAR response. There was no significant association between body weight and the persistence of IV or SC tocilizumab. Body weight was associated with the initial response to SC tocilizumab, although the difference in response was small, but not drug persistence. Physicians should monitor the body weight of patients and consider interventions to promote maintenance of a healthy weight.

PSXI-2 Impact of flexible prepartum supplementation strategies on cow-calf and subsequent progeny feedlot performance

Abstract Implementation of minimal supplemental protein strategies during late gestation may have the potential to minimize any negative postweaning progeny performance while decreasing feed costs. A 3-yr study was conducted to evaluate the effects of mid- to late-gestation supplementation strategies on reproduction, cow body weight (BW), and calf performance in May-calving mature cows grazing upland native range. Cows received one of 3 supplementation strategies: 1) 0.227 kg/d of a 30% CP distillers-based supplement (HalfSupp), 2) 0.454 kg/d of a 30% CP distillers-based supplement (Supp), or 3) brief and intermittent supplementation of Supp at 0.454 kg/cow based on periods of acute environmental stress, such as snow cover, wet winter events, and is best described as flexible supplementation (Flex). Supplementation was initiated in December each year and terminated approximately 30-d prior to the start of the calving season in April. Across all 3 yr, average supplement feeding rate was 25.5, 50.9, and 5.4 kg/cow during the 112-d supplemental period, which resulted in average yearly prepartum supplemental costs of $27.30, 54.60, and 1.99 for HalfSupp, Supp, and Flex; respectively. After weaning, steers grazed sub-irrigated meadow with a dried distiller grain supplement until May. In May, all steers grazed sub-irrigated meadow without additional supplement until August/September when steers were shipped to West Central Research and Extension Center (WCREC). Steers were placed in a GrowSafe feeding system for the rest of the finishing feeding period. Each year, steers were slaughtered at a commercial facility (Tyson Fresh Meats, Lexington, NE) when estimated visually to have 1.3 cm fat thickness over the 12th rib as a group. Cow BW was not different (P = 0.86) at the initiation of supplementation in Jan. However, cows fed Half had a lighter (P &amp;lt; 0.01) BW at pre-calving and tended (P = 0.08) to have a lighter BW at pre-breeding than their counterparts. After a 45-d breeding season, pregnancy rates were not influenced (P = 0.91) by prepartum supplementation strategies. Prepartum supplementation strategies did not influence (P &amp;gt; 0.56) preweaning calf BW at birth, pre-breeding, and weaning. In addition, steer backgrounding BW was also not influenced (P &amp;gt; 0.63) by prepartum supplementation strategy of their dam. Upon entry into the feedlot, steer BW was not impacted (P &amp;gt; 0.84) by prepartum supplementation strategy of their dam. Feedlot performance (BW, average daily gain, and feed efficiency) was not influenced (P &amp;gt; 0.59) by prepartum supplementation strategy of their dam. After harvest, all carcass characteristics were not impacted (P &amp;gt; 0.11) by the prepartum supplementation strategy of the dam. Considering the cost for prepartum supplementation, feeding a protein supplement just during environmentally stressful periods during gestation appears to be a viable alternative to more conventional methods and reduces winter feed costs.

PSXII-11 Impact of pre-breeding and breeding supplementation in May-born range heifers on growth rates and reproductive performance

Abstract Our objectives were to determine the impact rumen undegradable protein (RUP) supplementation prior to and during the breeding season had on growth rates and reproductive performance in May-born yearling range heifers. This study was conducted over a 3-yr period at the University of Nebraska, Gudmundsen Sandhills Laboratory (GSL) near Whitman, NE and utilized May-born Red Angus x Simmental crossbred heifers [n = 192; weaning body weight (BW) = 200 kg ± 28 kg]. Heifers were randomly assigned by pre-breeding BW to one of two treatments: 1) received 0.908 kg of a dried distillers grain supplement (DDGS; Supp, n = 66) pre-breeding through the breeding season or 2) received no supplement (NoSupp, n = 138). Each year, treatments were initiated in July and ended in August (55 ± 3 d). Using a C-Lock Smart Feeder (Rapid City, SD) heifers had individual access to their allotted DDGS supplementation. On average, NoSupp heifers consumed 0.09 kg/d (yr 1) and 0.02 kg/d (yr 2 and 3); whereas, Supp heifers averaged 0.59, 0.74, and 0.76 kg/d in yr 1, 2, and 3, respectively. Heifer BW was collected pre-trial (May), pre-breeding (July), breeding (August), pregnancy diagnosis (October), and pre-calving (April). Body condition score (BCS) was collected at pregnancy diagnosis (October) and pre-calving (April; Yr 1 and 2). Before each breeding season, two blood samples were collected 10 d apart to determine pubertal status. Heifers were synchronized with a single 5 mL intramuscular injection of prostaglandin F2 alpha (Lutalyse, Zoetis, Parsippany, NJ) 5 d after bull turnout during a 30 d natural service breeding season. Pregnancy diagnosis was determined via rectal ultrasound in October. No differences (P &amp;gt; 0.12) in BW were noted among treatments for all measurement timepoints. Moreover, SUPP heifers had greater (P &amp;lt; 0.02) average daily gain (ADG) from pre- trial to pregnancy diagnosis compared with NoSUPP heifers. However, there was no differences (P = 0.11) in ADG from pregnancy diagnosis to pre- calving. At pregnancy diagnosis (October), a treatment x year interaction (P = 0.02) for BCS was present where Supp heifers had a greater BCS than NoSupp heifers in yr 3. Heifer BCS pre-calving was not affected (P = 0.12) by treatment. There was a greater percentage (P &amp;lt; 0.01) of SUPP heifers cycling compared with NoSUPP heifers. However, there were no differences (P &amp;gt; 0.24) in pregnancy rates, the percentage that calved in the first 21 d, calf birth BW, or subsequent calving date. Ultimately, this study implies that providing a RUP supplement prior to and during the breeding season will increase the percentage of heifers that are cycling before breeding and have a greater ADG through pregnancy diagnosis; however, supplementation will not impact other reproductive parameters or BW gains.

Beta-caryophyllene attenuates experimental hepatocellular carcinoma through downregulation of oxidative stress and inflammation.

Hepatocellular carcinoma (HCC) is caused by various factors including toxic substances and xenobiotics. Numerous treatment strategies are used to address toxicity to the liver and HCC, yet their adverse effects are drawbacks. This study aimed to assess the effect of DEN/CCl4 on morphological changes in the liver, body weight, tumor incidence, and hematological tumor incidence, hematological parameters, hepatic markers, and histopathological analysis in mice following a preventive measure by using β-caryophyllene (BCP). Adult Balb/c mice were administered a single dose of DEN 1-mg/kg body weight and 0.2-mL CCl4/kg body weight intraperitoneal twice a week (i.p.) for 22 weeks. BCP was treated in one group of mice at 30-mg/kg body weight, intraperitoneal, for 7 weeks. BCP alone was treated in one group of mice at 300-mg/kg body weight intraperitoneal for 22 weeks. DEN/CCl4 caused a reduction in mice's body weight, which was significantly attenuated by BCP administration. BCP supplementation attenuated the tumor incidence DEN/CCl4 (100%) to about 25%. DEN/CCl4 caused alterations in the hematological parameters, serum total protein albumin globulin, A/G ratio, liver function markers (AST, ALT, ALP, GGT, ACP, and bilirubin), and lipid profile markers that were significantly reinstated by BCP administration. Oxidative stress markers (MDA, SOD, CAT, NO, LDH, and GST) were reduced by DEN/CCl4, which were significantly increased in BCP-treated groups. The liver histopathology alterations caused by DEN/CCl4 were amended considerably by BCP treatment. Immunohistochemical studies suggest that AFP, caspase-3, and COX-2 were chronically overexpressed in DEN/CCl4-exposed mice, notably attenuated by BCP administration. BCP suppressed tumor incidence by downregulating inflammation and inducing caspase-3-mediated apoptosis. Conclusively, BCP appears to be a potent natural supplement capable of repressing liver inflammation and carcinoma through the mitigation of oxidative stress and inflammation pathways.

PSXIII-8 Determining the effects of selenium content of high-selenium forages on weight gain in growing lambs

Abstract High selenium (Se) forages grow on seleniferous soils in many parts of the world and upon Se-contaminated rangelands such as in the Western Phosphate Resource Area in the western United States. When consumed in large enough amounts or for extended durations, animals can be poisoned, developing acute or chronic selenosis. Naïve livestock will indiscriminately consume forage with increased concentrations of Se if available. However, most animals upon ingesting a sublethal Se dose will become averted to Se-rich plants and select forages with decreased Se concentrations. The purpose of this study was to determine Se concentrations in feed that cause reduced feed intake and decreased body weight (BW) gain in growing lambs (6 to 8 mo of age). Lambs (n = 5) were randomly divided into four groups and were fed a control pellet (&amp;lt; 1 ppm Se) at 1.5% of their BW and had free choice to a custom Se alfalfa pellet containing &amp;lt; 1 (control), 10, 20, or 40 ppm Se for 8 wk. During the 8 wk period the lambs gained 32.9 ± 4.1, 27.8 ± 1.8, 18.9 ± 9.2, and 7.4 ± 2.8% (mean ±SD) of their initial BW in the &amp;lt; 1 (control), 10, 20, or 40 ppm Se groups, respectively. After the 8 wk were completed, the lambs were fed only the custom Se alfalfa pellets, with &amp;lt; 1 (control), 10, 20, or 40 ppm Se, free choice for four additional weeks. As Se concentration in the pellets fed increased, the feed intake and BW gains significantly decreased. Lambs in the control and 10 ppm Se groups ate approximately 2-fold more than the lambs in the 40 ppm Se group, which lost over 3% of their initial BW. Understanding the concentration of Se in forages and how it affects appetite and BW gain allows range managers to better manage seleniferous or Se-contaminated ranges to safely use sheep on these types of rangelands. Additional work is needed to better understand the management of other livestock species grazing on high Se-containing ranges and pastures.

PSXII-26 The influence of protein supplementation in beef cows during early lactation on growth performance, carcass characteristic and meat quality of progeny

Abstract At 11 ± 4 d of lactation, 30 multiparous Angus cows [body weight (BW) = 476 ± 17 kg, body condition score (BCS) = 4.5 ± 0.3) were stratified by BW and allotted in 6 pens (5 cows/pen). During 75 d of experiment, all pens received ad libitum low quality hay (Panicum italicum; 54.7% TDN, 6.1% CP DM basis) and were randomly assigned to one of two treatments: 1) PS; cows received ad libitum 30% CP supplement including an intake limiter component (Controlmix, Nutralmix SRL, Argentina), or 2) NS; cows were not supplemented. After the experimental period, dams and their calves (PS: 7 males and 8 females; NS: 8 males and 7 females) were managed on improved pastures as a single group until weaning at 213 d of age. After weaning, heifer and steer calves were reared on improved pastures until 448 d of age, then placed into a feedlot with a finishing diet during 73 d until slaughter. Pens were considered the experimental unit and data were analyzed using the PROC MIXED of SAS, considering treatment and sex as a fixed effects and pen as a random effect. Overage dry matter intake (DMI) of hay was not affected by treatments (P &amp;gt; 0.10), and DMI of supplement in PS cows was 4.4 kgּ cow-1ּ d-1. Milk production was greater in PS than NS cows (PS: 5.3, NS: 3.6 kgּ cow-1ּ d-1; P &amp;lt; 0.01). Progeny from PS cows increased BW at weaning (PS: 180, NS: 141 kg; P &amp;lt; 0.01), BW at initial feedlot phase (PS: 300, NS: 252 kg; P = 0.01) and final BW (PS: 415, NS: 354 kg; P = 0.01). After slaughter, progeny from PS cows tended to have increased dressing percentage (PS: 59.0, NS: 58.1%; P = 0.09), had an increased hot carcass weight (PS: 227, NS: 191 kg; P &amp;lt; 0.01), and increased Longissimus muscle (LM) area (PS: 68.5, NS: 60.1 cm2; P = 0.02), while rib fat thickness was not affected by treatments (PS: 7.8, NS: 7.6 mm; P = 0.68). There was no effect of protein supplementation on color (L*, a*, b*) and pH of LM at 24 h postmortem (P &amp;gt; 0.10). In addition, moisture, ether extract and shear force of LM after 4 d of aging were similar between treatments (P &amp;gt; 0.10). There was no treatment × sex interaction for any variables (P &amp;gt; 0.10). This study showed that protein supplementation during early lactation improved growth performance and carcass quality, but did not result in enhanced meat quality of progeny.

PSI-18 Intra-articular triamcinolone acetonide administration does not affect microbial culture or synovial fluid volume in young, exercising Quarter Horses

Abstract Intra-articular corticosteroids (IAC) are administered to horses experiencing joint inflammation, at times with a concurrent articular antibiotic for prophylaxis. However, information regarding the biologic effects of IAC and potential for microbial contamination in IAC-administered joints is limited in young, exercising horses. The objective of this study was to evaluate the impact of IAC on traditional microbial culture, synovial fluid (SF) volume, and the presence of IAC; hypothesizing negative microbial culture, no change of SF volume, and detection of IAC in SF post-administration. To test this, 2-yr-old Quarter Horses {n = 24; body weight (BW) = 409 ± 6 kg; 825 ± 21 d of age; 12 fillies, 12 geldings) were stratified by BW, age, and sex, and randomly assigned to 1 of 3 treatment groups for a 56-d trial. Horses were housed individually in stalls with runs and fed concentrate offered at 0.75% BW/d split evenly every 12 h with ad libitum Coastal bermudagrass hay and water. Every 21 d, BW and body condition score (BCS) were recorded, and concentrate was adjusted accordingly. Horses were exercised 5 d/wk, up to 45 min/d in a progressive workload using a free-stall exerciser. Blood was collected post-exercise during wk 1, 4, and 7 via jugular venipuncture and lactate (BL) was measured to monitor increasing workload. Intra-articular treatments consisted of 0 mg (CON; n = 8), 6 mg (CORT6; n = 8), or 12 mg (CORT12; n = 8) of triamcinolone acetonide (TA). On d 0, treatments were administered in one randomly selected radiocarpal joint per horse. Following aseptic preparation, SF from both radiocarpal joints was collected before administration (pre), and on d 7, 14, 28, and 56. Volume of SF was recorded, and standard microbial culture and detection of TA were performed by a commercial laboratory. Data were analyzed using PROC MIXED (BW, BCS, BL, SF volume) and PROC GLM (TA) of SAS. For SF volume, data from the contralateral radiocarpal joint were used as a covariate. Horses increased BW and BCS over time (P ≤ 0.01) across treatments. Post-exercise BL increased from wk 1 to 4 and remained increased through wk 7 (P &amp;lt; 0.01). Microbial culture for all horses and time points were negative. Concentration of TA was not evaluated on d 7 due to limited SF volume, but TA was detected on d 14 and concentration did not differ between CORT6 and CORT12 (P = 0.13). Recorded SF volume did not change from d 0 (pre) to 7 but increased to d 56, regardless of treatment (P &amp;lt; 0.01). These results indicate that, based on standard culture, TA administration did not result in positive microbial culture, or decrease SF volume in young horses undergoing regular exercise, however, TA was detectable to d 14.

PSXIII-20 Impact of Aspergillus oryzae fermentation-derived prebiotic-like additive combined with monensin on feedlot performance in finishing steers

Abstract The aim of this study was to investigate the effects of supplementing a prebiotic-like action additive product derived from the fermentation of Aspergillus oryzae (AM; 2 g Amaferm/d) in combination with monensin throughout the entire feedlot period. The primary objective was to evaluate the impact of this dietary intervention on feedlot performance, focusing on parameters such as feed intake, feed-to-gain ratio, body weight (BW), average daily gain (ADG), and carcass quality. Steers (n = 1,200), aged approximately 18 mo with an initial BW of 307.8 ± 17 kg, were randomly assigned to 8 pens (150 steers per pen) and each pen was randomly assigned to two treatments: a control diet with monensin (M; monensin supplemented at 33 mg/kg DM) and a treatment diet with the addition of AM (M+AM; monensin supplemented at 33 mg/kg DM and 2 g Amaferm/d). The feedlot period comprised three steps, with daily feed delivery adjustments using a feed bunk management system. A multilevel model using the PROC MIXED procedure of SAS with pen as experimental unit, was employed to evaluate feed intake, feed to gain ratio, BW and ADG for each period, also including effects on carcass quality and growth measured by ultrasound (random sample of 45 animals per pen; 30% of each pen). No significant differences were observed in feed intake across the three diet steps (P &amp;gt; 0.10). During the adaptation period, steers fed AM had greater ADG (+0.168 kg/d; P = 0.003) and increased BW at d 20 (+5.5 kg; P &amp;lt; 0.001). Although ADG during the finishing phase was similar for both treatments, a trend was observed for greater BW at d 108 (+4.6 kg; P = 0.095) when supplemented with AM. The inclusion of AM showed no impact on feed-to-gain ratio for the entire period (P = 0.589). In the finishing period, a positive effect on ribeye area (REA) growth rate (+0.54 cm2/mo; P = 0.016) and a trend towards greater back fat deposition rate (+0.11 mm/mo; P = 0.069) were observed with AM supplementation. At the end of the finishing period, a trend towards greater REA (+1.39 cm2; P = 0.101) was noted with no differences in back fat. Overall, this study demonstrates that the addition of AM throughout the feedlot period positively influenced the productive response during the adaptation period, leading to improvements in carcass growth during the finishing period.